Bedfont Scientific Limited

Bedfont Scientific will be launching NewMed and exhibiting the new PEMF Magnetovital treatment mat at the Wellbeing Symposium 2014 to be held at the Kent Event Centre, Detling Showground, Kent on 19th November 2014.

NICE has recommended FeNO testing to help diagnose asthma in adults and children when diagnosis is unclear.

The Bedfont NObreath® is mentioned in new draft guidance recommending the use of simple, non-invasive testing to help diagnose and treat asthma.  The report is produced by NICE, the National Institute for Health and Care Excellence.

Performance Observation of latest INO Therapy monitor in NOXBOX Range

Following the success of the NOxBOX+ and NOxBOXO2 monitors for INO therapy, Bedfont Scientific have now designed and launched the NOxBOXi Intelligent INO Delivery and Monitoring System.

Latest addition to the Bedfont product family showcased at DDF

The European Business Awards has announced today that Bedfont Scientific is to represent the UK as a National Finalist in the prestigious 2012/13 Awards programme.

Following the successful UK launch of Bedfont Scientific Ltd’s new breath hydrogen (H2) and Methane (CH4) monitor, ‘GastroCH4ECK™’ is back in stock and set to make it’s international debut.

Bedfont Scientific announced today that they now have completed registration to sell GastroCH4ECK™ Gastrolyzer® in Italy.

Kent based medical breath monitoring manufacturer, Bedfont Scientific Ltd has agreed the acquisition of Logan Research Ltd in a deal to move the company into a new area of scientific applications for breath research.